Rochester, MINNESOTA1 Active Studies

Eosinophilic Esophagitis Clinical Trials in Rochester, MINNESOTA

Find 1 actively recruiting eosinophilic esophagitis clinical trials in Rochester, MINNESOTA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
308
Enrolling

Recruiting Eosinophilic Esophagitis Studies in Rochester

About Eosinophilic Esophagitis Clinical Trials in Rochester

Eosinophilic esophagitis (EoE) is a chronic allergic/immune condition where eosinophils accumulate in the esophagus, causing inflammation and difficulty swallowing. Prevalence has been increasing in recent decades. Treatment includes dietary elimination, proton pump inhibitors, and topical corticosteroids.

There are currently 1 eosinophilic esophagitis clinical trials recruiting participants in Rochester, MINNESOTA. These studies are seeking a combined 308 participants. Research is being sponsored by Dr. Falk Pharma GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.

Eosinophilic Esophagitis Clinical Trials in Rochester — FAQ

Are there eosinophilic esophagitis clinical trials in Rochester?

Yes, there are 1 eosinophilic esophagitis clinical trials currently recruiting in Rochester, MINNESOTA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What eosinophilic esophagitis treatments are being tested?

The 1 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for eosinophilic esophagitis.

Data updated March 2, 2026 from ClinicalTrials.gov